Basic characteristics of the 23 SFTS patients who received favipiravir.

NIAID Data Ecosystem2026-03-12 收录

数据链接：

https://figshare.com/articles/dataset/Basic_characteristics_of_the_23_SFTS_patients_who_received_favipiravir_/14077470 数据链接链接失效反馈

官方服务：

资源简介：

Basic characteristics of the 23 SFTS patients who received favipiravir.

创建时间：

2021-02-22

datasheet1_No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison.docx

COVID-19

病毒药物疗效

Objectives: No specific treatment has been approved for COVID-19. Lopinavir/ritonavir (LPV/r) and hydroxychloroquine (HCQ) have been used with poor results, and a trial showed advantages of combined a

NIAID Data Ecosystem30

Single or multiple-dose regimen of TIP in PVM infection did not have an effect on weight loss, clinical score and lung cellular response.

病毒药物疗效

动物呼吸道感染模型

A: Change in body weight expressed as the percentage of the original weight of PVM-infected mice that received 80 µg of TIP in 60 µl saline (black bars) or saline (white bars) on day 5 after infection

Figshare2016-02-23 更新20

Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients

慢性乙型肝炎治疗

病毒药物疗效

Background The efficacy of switching to tenofovir disoproxil fumarate (TDF) monotherapy from lamivudine (LAM) plus adefovir dipivoxil (ADV) combination therapy (stable switching) in patients with LAM-

NIAID Data Ecosystem10

Favipiravir and zanamivir clear influenza B infection in an immunocompromised child

病毒药物疗效

流感B感染

Data associated with a long-term influenza B infection in an immunocompromised child. These data replace the earlier submission PRJNA545892, reflecting an update in our pipeline for removing human seq

NIAID Data Ecosystem30

Patient Characteristics (Categorical Variables).

病毒药物疗效

临床患者分组

AZT = zidovudine, 3TC = lamivudine, EFV = efavirenz, NVP = nevirapine.Chi-square test p-values for difference in failure proportions by group, among patients included in the primary analysis: apbpPati

Figshare2015-12-02 更新10

Basic characteristics of the 23 SFTS patients who received favipiravir.

资源简介：

相关数据集